C4 Therapeutics (CCCC) Other Working Capital Changes (2019 - 2026)
C4 Therapeutics has reported Other Working Capital Changes over the past 8 years, most recently at -$122000.0 for Q1 2026.
- For Q1 2026, Other Working Capital Changes fell 569.23% year-over-year to -$122000.0; the TTM value through Mar 2026 reached -$19.0 million, down 33.61%, while the annual FY2025 figure was -$18.8 million, 535.21% down from the prior year.
- Other Working Capital Changes for Q1 2026 was -$122000.0 at C4 Therapeutics, up from -$8.7 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $20.9 million in Q4 2022 and troughed at -$21.1 million in Q2 2024.
- A 5-year average of -$1.0 million and a median of -$122000.0 in 2026 define the central range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 1140.14% in 2022 and fell as far as 33163.93% in 2022.
- Year by year, Other Working Capital Changes stood at $20.9 million in 2022, then tumbled by 86.86% to $2.7 million in 2023, then tumbled by 98.98% to $28000.0 in 2024, then plummeted by 31103.57% to -$8.7 million in 2025, then soared by 98.59% to -$122000.0 in 2026.
- Business Quant data shows Other Working Capital Changes for CCCC at -$122000.0 in Q1 2026, -$8.7 million in Q4 2025, and -$7.3 million in Q3 2025.